Prior Authorization: Minor Inconvenience or Threat to Pharma Viability?

Pharmaceutical Processing | Dan Rubin, CEO | December 1, 2016

Tackling the Prior Authorization Challenge

The commercial dynamics facing the pharmaceutical industry have shifted in recent years.  It is no longer sufficient to market pharmaceutical products based solely on efficacy and side effect profile, or to contract with managed care for formulary positions. It has become vitally important for pharma to help physicians navigate the complex maze of patient access due to managed care restrictions, in order to help patients receive the best treatment for their condition.  Read the full article